Paper73379
An artefact in clonogenic assays of bleomycin cytotoxicity.
Twentyman PR. Br J Cancer, 1977. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. An artefact in clonogenic assays of bleomycin cytotoxicity. Papers, record 73379. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/73379
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bleomycin | Major topic |
| Clone Cells | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Cell Survival | |
| In Vitro Techniques | |
| Male | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4142871 | Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin. | Gan | 1974 | https://conductscience.org/library/papers/4142871 | PubMed |
| 2 | 4143273 | The sensitivity to bleomycin of a solid mouse tumour at different stages of growth. | Br J Cancer | 1974 | https://conductscience.org/library/papers/4143273 | PubMed |
| 3 | 4647494 | Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. | J Natl Cancer Inst | 1972 | https://conductscience.org/library/papers/4647494 | PubMed |
| 4 | 4684814 | Repair of potentially lethal radiation damage in vitro and in vivo. | Radiology | 1973 | https://conductscience.org/library/papers/4684814 | PubMed |
| 5 | 55271 | Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. | Br J Cancer | 1975 | https://conductscience.org/library/papers/55271 | PubMed |
| 6 | 836758 | Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. | Br J Cancer | 1977 | https://conductscience.org/library/papers/836758 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7640216 | Mechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7640216 | PubMed |
| 7225287 | In vivo combination of misonidazole and the chemotherapeutic agent CCNU. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7225287 | PubMed |
| 7000124 | Experimental chemotherapy studies: intercomparison of assays. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000124 | PubMed |
| 7000122 | Analysis of tumour responses by excision and in vitro assay of cellular clonogenic capacity. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/7000122 | PubMed |
| 6177286 | Modulation of bleomycin cytotoxicity. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6177286 | PubMed |
| 6175649 | Differential survival of cell subpopulations in spheroids after treatment with bleomycin. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/6175649 | PubMed |
| 6158976 | Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/6158976 | PubMed |
| 6157635 | Effect of tumor dissaggregation on results of in vitro cell survival assay after in vivo treatment of the EMT-6 tumor: x-rays, cyclophosphamide, and bleomycin. | In Vitro | 1980 | https://conductscience.org/library/papers/6157635 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/73379
GET https://conductscience.org/api/papers/v1/73379/authors